{"url_path":"/sec/cik-0001106838/10-k/2026/item-16","section_key":"item-16","section_title":"Item 16 10-K Summary**","topic":"sec","document":{"doc_type":"10-K/A","doc_date":"2026-07-17","source_url":"https://www.sec.gov/Archives/edgar/data/1106838/0001493152-26-033712-index.html","accession_number":"0001493152-26-033712","cik":"0001106838","ticker":null,"issuer_name":"Sonnet BioTherapeutics Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1106838/0001493152-26-033712-index.html","primary_entity_key":"0001106838","primary_entity_name":"Sonnet BioTherapeutics Holdings, Inc."},"word_count":71,"has_tables":true,"body_markdown":"**Item\n16. 10-K Summary**\n\n \n\nNone.\n\n \n\n4\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed\non its behalf by the undersigned, thereunto duly authorized.\n\n \n\n \n \n**Sonnet\nBioTherapeutics Holdings, Inc.**\n\n \n \n(Registrant)\n\n \n \n \n\nDate:\nJuly 17, 2026\n \n*/s/\nRaghu Rao*\n\n \n \nRaghu\nRao\n\n \n \nChief\nExecutive Officer\n\n \n \n(Principal\nExecutive Officer, Principal Financial and Accounting Officer and sole Director)\n\n \n\n5"}